1. Intralesional rituximab in the treatment of indolent primary cutaneous B‐cell lymphoma. (1st February 2021) Authors: Chirico, A.; Henderson Berg, M.H.; Roberge, D.; Pehr, K. Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intralesional rituximab in the treatment of indolent primary cutaneous B‐cell lymphoma. (24th September 2020) Authors: Chirico, A.; Henderson Berg, M.H.; Roberge, D.; Pehr, K. Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1748 A DECT framework to measure the effect of radiation dose on lung function after radiotherapy. (May 2022) Authors: Simard, M.; Lapointe, A.; Bahig, H.; Carrier, J.; Zhang, S.; Campeau, M.; Filion, É.; Roberge, D.; Bouchard, H.; Bedwani, S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Cancer Patient's Use and Appreciation of the Internet and other Modern Means of Communication. (October 2014) Authors: Katz, J. E.; Roberge, D.; Coulombe, G. Journal: Technology in cancer research & treatment Issue: Volume 13:Number 5(2014) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗